Does your enlarged prostate force you to wake up multiple times each night to urinate? HoLEP (Holmium Laser Enucleation of the Prostate) and Aquablation are two surgical approaches for treating moderate to severe BPH when medications prove insufficient. HoLEP uses laser energy to remove prostate tissue through the urethra, while Aquablation employs a robotically controlled water jet guided by real-time ultrasound imaging.
Both procedures aim to restore normal urine flow by removing obstructing prostate tissue. They differ in technique, recovery profiles, and suitability for different prostate sizes. The choice depends on prostate anatomy, symptom severity, such as frequent urination, weak urine stream, or difficulty emptying the bladder completely, and individual health factors.
HoLEP: Laser Enucleation Technology
HoLEP removes the entire enlarged portion of the prostate using a holmium laser that delivers energy pulses. The surgeon inserts a thin telescope through the urethra. They use the laser to separate the overgrown prostate tissue from the capsule, similar to peeling an orange from its skin. The separated tissue moves into the bladder. There, a morcellator (a device that breaks tissue into smaller fragments) cuts it into smaller pieces for removal.
The procedure typically takes a certain amount of time, depending on prostate size. HoLEP can treat prostates of any size. The laser seals blood vessels during cutting. This results in minimal bleeding even in patients taking blood thinners.
Technical Advantages
The holmium laser creates a plane between the adenoma (overgrown tissue that causes enlargement) and the surgical capsule (the outer layer of the prostate). This anatomical approach removes obstructing tissue whilst preserving the peripheral zone (the outer region of the prostate) where prostate cancer typically develops. The complete removal means tissue regrowth rarely occurs.
Surgeons can send the removed tissue for pathological examination (laboratory analysis to check for abnormalities). This enables the detection of unexpected prostate cancer in some cases. The procedure maintains the bladder neck anatomy. This can help reduce the risk of retrograde ejaculation (when semen enters the bladder instead of exiting the penis) compared to traditional transurethral resection.
Aquablation: Robotic Water Jet Therapy
Aquablation combines robotic technology with real-time imaging to remove prostate tissue using a high-velocity saline jet (a focused stream of sterile saltwater). The surgeon first performs a transrectal ultrasound (a scan using sound waves inserted through the rectum) to create a detailed prostate map. They then use software to plan the treatment area. The robotic handpiece executes this plan autonomously, delivering the water jet whilst the surgeon monitors progress.
The procedure typically completes in a short period of actual resection time (the time spent removing tissue). Total operating time includes planning and haemostasis (controlling bleeding after tissue removal). Aquablation is suitable for prostates of varying sizes. The water jet selectively removes soft adenomatous tissue (the enlarged prostate tissue causing symptoms). It can help preserve more complex structures, such as the bladder neck and verumontanum (a small mound in the urethra necessary for ejaculation).
Imaging-Guided Treatment
Real-time ultrasound guidance allows surgeons to customise treatment boundaries for each patient’s anatomy. The system can create asymmetric resection patterns when the prostate enlargement isn’t uniform. It can adjust depth and angle to match the prostate’s contours. This customisation can help preserve ejaculatory function by avoiding the verumontanum and the ejaculatory ducts (the tubes that carry semen during ejaculation).
The automated execution reduces variability in hand movements and fatigue-related inconsistencies. Once the surgeon approves the treatment plan, the robot performs the resection pattern regardless of prostate size or density variations.
Recovery Profiles and Timeline
HoLEP patients typically stay overnight with a catheter (a thin tube that drains urine from the bladder) for a short period. Initial urinary symptoms include:
- Frequency
- Urgency
- Mild burning during urination
These symptoms gradually improve over several weeks. Most men can resume normal activities within about a week. However, they should avoid heavy lifting for a few weeks. Complete healing with improved urine flow can occur within several weeks to a few months.
Aquablation patients may require catheterisation for several days, depending on bleeding control measures used. The recovery timeline parallels HoLEP, with temporary irritative symptoms (such as frequent urination, urgency, or burning sensations) resolving over several weeks. Some centres perform Aquablation as an outpatient procedure, though overnight observation remains common.
Managing Recovery Expectations
Both procedures cause temporary stress incontinence (small leaks of urine when coughing, sneezing, or straining) in some patients as the bladder adjusts to unobstructed flow. This can be resolved within several weeks with pelvic floor exercises. Patients should expect blood-tinged urine intermittently for several weeks as healing tissue sloughs off.
Sexual function recovery varies between procedures. HoLEP commonly causes retrograde ejaculation. This means semen enters the bladder instead of exiting through the penis. Aquablation’s preservation of anatomical structures can result in maintained antegrade ejaculation (normal forward ejaculation) in many patients. However, everyone experiences changes in ejaculatory volume or sensation differently. Consult with your doctor to discuss what to expect based on your specific situation.
Effectiveness and Durability
HoLEP demonstrates durability with retreatment rates remaining low at 10 years. International Prostate Symptom Scores (IPSS), a standardised questionnaire that measures urinary symptom severity, typically improve from severe ranges to mild ranges. Maximum urinary flow rates can increase from restricted flows to normal ranges. Post-void residual volumes can decrease from elevated levels to near-complete emptying. Post-void residual volume is the amount of urine remaining in the bladder after urination.
Aquablation shows comparable short to medium-term results. IPSS improvements match HoLEP outcomes through several years of follow-up data. Flow rate improvements and symptom relief remain stable. Longer-term data continues accumulating as the technology has gained approval more recently than HoLEP.
💡 Did You Know?
The holmium laser used in HoLEP operates at a wavelength specifically absorbed by water molecules in tissue. This creates cutting with minimal thermal spread to surrounding structures. This property also makes it useful for kidney stone fragmentation.
Candidate Selection Factors
Prostate size influences procedure selection. HoLEP can handle any prostate size, including large glands that would otherwise require open surgery. Aquablation is suitable for small to large prostates, with consistent results across this range.
Anatomical considerations (the shape and structure of your prostate) matter for both procedures. Middle lobe enlargement (when the central part of the prostate protrudes into the bladder) responds to both techniques. HoLEP may be suitable for asymmetric growth patterns (where the prostate has grown unevenly) through manual control. Aquablation is suitable for symmetric enlargement (even growth on all sides) where the automated resection pattern matches natural anatomy.
Medical Considerations
Anticoagulation status, whether you take blood-thinning medications, affects procedure choice. HoLEP’s haemostasis, or the ability to control bleeding, allows treatment of patients on blood thinners with appropriate bridging protocols (a plan to temporarily adjust your medication). Aquablation typically requires stopping anticoagulation due to a higher bleeding risk. Techniques continue evolving to improve haemostasis.
Patient fitness for anaesthesia (your ability to safely undergo the numbing medication needed during surgery) influences selection. Both procedures require general or spinal anaesthesia. HoLEP’s longer operative time may pose challenges for patients with significant cardiopulmonary disease (serious heart or lung conditions). Aquablation’s shorter resection time can reduce anaesthesia exposure but may require additional time for bleeding control in some cases.
Potential Complications and Risk Management
HoLEP complications occur infrequently. They include:
- Bladder injury during morcellation (when tissue is cut into smaller pieces for removal, which happens rarely
- Temporary stress incontinence (loss of bladder control when coughing or sneezing) occurs in some cases
- Urethral stricture (narrowing of the tube that carries urine out of the body) happens infrequently
The learning curve for surgeons is steep. Complication rates decrease after gaining experience with multiple cases. Healthcare professionals trained in the procedure report few serious complications.
Aquablation’s primary concern involves bleeding requiring transfusion. This occurs in some cases. Post-procedure bleeding control techniques, including bladder neck cauterisation (using heat to seal blood vessels) or prostate artery embolisation (blocking blood vessels to reduce bleeding), may extend procedure time. Temporary incontinence rates mirror HoLEP. Stricture formation appears less common, given the absence of thermal energy.
Risk Mitigation Strategies
Pre-procedure planning can help reduce complications for both techniques. Cystoscopy (a procedure where a doctor uses a thin camera to examine your bladder and urethra) confirms anatomy and rules out bladder pathology. Urodynamic studies (tests that measure how well your bladder stores and releases urine) in complex cases make sure symptoms stem from obstruction rather than bladder dysfunction. A prostate MRI (an imaging scan) may identify suspicious lesions requiring a biopsy (where the doctor removes a small tissue sample for testing) before definitive BPH treatment.
Post-procedure protocols help minimise complications through careful catheter management (a temporary tube to drain urine), appropriate antibiotics, and activity restrictions. Regular follow-up enables early detection of strictures or persistent symptoms requiring intervention.
Making Your Treatment Decision
Consider these factors when choosing between HoLEP and Aquablation:
- Prostate size and shape: Very large or asymmetric (irregular) prostates may be more suitable for HoLEP.
- Ejaculatory function priority: Aquablation may offer preservation potential.
- Anticoagulation needs: HoLEP may accommodate blood thinner requirements.
- Surgeon experience: HoLEP requires specialised training and experience.
- Recovery preferences: Similar timelines but different symptom patterns.
Discuss your specific anatomy, symptoms, and priorities with your urologist (a doctor who specialises in urinary and male reproductive health). Review imaging studies (such as ultrasound or MRI scans) together to understand your prostate’s characteristics. Your urologist can help determine which procedure may be appropriate for your individual situation. Consider second opinions if uncertainty exists, particularly for complex cases or when preservation of sexual function is important.
When to Seek Professional Help
Consult a urologist if you experience:
- Inability to urinate requiring emergency catheterisation (the insertion of a thin tube to drain urine when you cannot pass it naturally)
- Frequent night-time urination that disrupts your sleep (waking up multiple times to use the bathroom)
- Recurrent urinary tract infections (repeated infections that can cause burning, urgency, or discomfort when you urinate)
- Visible blood in your urine
- Incomplete bladder emptying sensation with dribbling (feeling like your bladder hasn’t fully emptied, followed by leaking)
- A weak stream that requires straining to urinate
- Bladder stones detected on imaging (hard mineral deposits found during scans such as X-rays or ultrasounds)
- Kidney function changes related to obstruction (blockage affecting how your kidneys filter waste)
Commonly Asked Questions
How long do the benefits of HoLEP and Aquablation last?
HoLEP shows durable results beyond many years with minimal tissue regrowth. Aquablation demonstrates stable outcomes through several years of available data, with expectations of similar long-term durability based on the tissue removal achieved.
Can these procedures be repeated if symptoms return?
Both procedures can technically be repeated, though necessity is rare. HoLEP’s enucleation (removal of the inner prostate tissue) leaves little tissue to regrow. If symptoms recur years later, they typically stem from bladder changes rather than prostate regrowth. These symptoms may require different management approaches.
What happens to PSA levels after these procedures?
PSA levels (a protein produced by the prostate that is measured in blood tests) decrease proportionally to the tissue removed. They typically drop substantially after either procedure. Your urologist should consider this reduction when monitoring for prostate cancer. Your urologist can establish new baseline PSA levels several months after the procedure for future comparison.
How soon can I return to exercise and sexual activity?
Light walking begins immediately to prevent blood clots. Regular exercise resumes after a few weeks. Avoid heavy lifting and straining for several weeks. Sexual activity typically resumes after the catheter is removed once you feel comfortable, usually within a few weeks, depending on individual healing.
Will I still need BPH medications after surgery?
Many men discontinue BPH medications (drugs that help relax the prostate or reduce its size) after surgical intervention. The surgery mechanically resolves the obstruction. Some may continue medications temporarily during healing or long-term if bladder symptoms persist despite adequate prostate tissue removal.
Next Steps
HoLEP provides proven long-term outcomes for any prostate size, while Aquablation combines robotic technology with potential for ejaculatory function preservation. Your choice depends on prostate anatomy, bleeding risk factors, and sexual function priorities. Discuss imaging studies and symptom patterns with your urologist to determine which approach suits your specific situation.
If you’re experiencing frequent nighttime urination, a weak urine stream, or incomplete bladder emptying, consult a urologist to evaluate your condition and discuss whether HoLEP, Aquablation, or other BPH treatments may be appropriate for you.
